Tonix Pharmaceuticals Holding Corp. (TNXP)

NASDAQ: TNXP · IEX Real-Time Price · USD

0.560

-0.011 (-1.86%)

At close: Jul 19, 2024, 12:00 AM

0.580

+0.020 (3.53%)

Pre-market: Jul 22, 2024, 9:13 AM EDT

TNXP Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2008
Net Income	-98.59	-116.66	-116.88	-92.29	-52.17	-31.09	Upgrade
Depreciation & Amortization	4.61	4.29	1.25	0.05	0.03	0.03	Upgrade
Share-Based Compensation	8.17	9.28	10.91	7.9	2.88	1.46	Upgrade
Other Operating Activities	-0.86	1.09	-0	8.78	-1.01	0.45	Upgrade
Operating Cash Flow	-86.67	-102	-98.05	-75.56	-48.57	-26.68	Upgrade
Capital Expenditures	-3.21	-6.9	-48.15	-35.31	-8.56	-0.02	Upgrade
Acquisitions	-22.17	-22.17	0	0	0	0	Upgrade
Investing Cash Flow	-25.38	-29.07	-48.15	-35.31	-8.56	-0.02	Upgrade
Share Issuance / Repurchase	16.53	5	94.5	212.49	118.5	5.94	Upgrade
Debt Issued / Paid	8.71	8.94	0	0	0	0	Upgrade
Other Financing Activities	22.57	22.57	-6.66	-	4.6	6.98	Upgrade
Financing Cash Flow	47.81	36.52	87.84	212.49	123.11	12.92	Upgrade
Exchange Rate Effect	-0.03	-0.07	-0.07	-0.03	-0.02	-0	Upgrade
Net Cash Flow	-64.27	-94.62	-58.43	101.59	65.96	-13.79	Upgrade
Free Cash Flow	-89.87	-108.9	-146.2	-110.86	-57.13	-26.7	Upgrade
Free Cash Flow Margin	-876.80%	-1401.89%	-	-	-	-	Upgrade
Free Cash Flow Per Share	-35.56	-204.51	-800.90	-1947.15	-3865.37	-106231.03	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).